SCHEMBL462327

SCHEMBL462327

FC(F)(F)Cc1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 3/20 0.54
SLC6A2 P23975 2/20 0.54
SLC6A3 Q01959 2/20 0.54
HTR2A P28223 1/20 0.54
HRH1 P35367 1/20 0.54
HTR2B P41595 1/20 0.54
CHRNA4 P43681 1/20 0.54
IDO1 P14902 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.44
TAAR1 Q96RJ0 2/20 0.42
LMNA P02545 2/20 0.42
CYP2A6 P11509 1/20 0.42
GAA P10253 1/20 0.41
AGXT P21549 2/20 0.41
ALDH1A1 P00352 3/20 0.39
MAPT P10636 1/20 0.39
KCNH2 Q12809 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7670360 0.86 ESR1 (0.38) SLC6A4SLC6A2SLC6A3HTR2AHRH1
SCHEMBL4108567 0.79 CA1 (0.38) SLC6A4SLC6A2SLC6A3HTR2AHRH1
SCHEMBL29299426 0.78 SLC6A4 (0.48) SLC6A4SLC6A2SLC6A3HTR2AHRH1
SCHEMBL11515369 0.77 SLC6A4 (0.42) SLC6A4SLC6A2SLC6A3HTR2AHRH1
SCHEMBL10570 0.76 ALDH1A1 (0.52) TAAR1ALDH1A1MAPTMEN1KMT2A
SCHEMBL3658885 0.76 SLC6A4 (0.56) SLC6A4SLC6A2SLC6A3HTR2AHRH1
SCHEMBL10248786 0.76 IDO1 (0.48) IDO1TAAR1LMNAAGXT
SCHEMBL11059680 0.75 TAAR1 (0.50) SLC6A4SLC6A2SLC6A3HTR2AHRH1
SCHEMBL16959914 0.75 PIK3CA (0.41) SLC6A4SLC6A3IDO1TAAR1GAA
SCHEMBL25471464 0.74 TRPA1 (0.43) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112676307-A Method for reducing and recycling catalyst residues 江苏优普生物化学科技股份有限公司 2021-04-20 CN claimed
CN-114181074-A Preparation method of p-chlorobenzoyl fluoride 大连奇凯医药科技有限公司 2022-03-15 CN disclosed
CN-113710788-A Solvent composition and use thereof 株式会社金子化学 2021-11-26 CN disclosed
CN-113661203-A Acrylic modified polymeric sunscreen agents for use in organic media 阿科玛股份有限公司 2021-11-16 CN disclosed
US-20210147408-A1 SMALL MOLECULE INHIBITORS OF GALECTIN-3 BRISTOL MYERS SQUIBB CO (US) 2021-05-20 US disclosed
US-20210147408-A1 SMALL MOLECULE INHIBITORS OF GALECTIN-3 BRISTOL MYERS SQUIBB CO (US) 2021-05-20 US disclosed
CN-112676307-A Method for reducing and recycling catalyst residues 江苏优普生物化学科技股份有限公司 2021-04-20 CN disclosed
CN-112624906-A P-trifluoromethylaniline rectification kettle residue treatment process 江苏优普生物化学科技股份有限公司 2021-04-09 CN disclosed
CN-108349883-B Method for synthesizing 2-alkyl-4-trifluoromethyl-3-alkylsulfonylbenzoic acid 拜耳作物科学股份公司 2020-10-23 CN disclosed
CN-107636038-B Reactive compositions containing mercapto-functional silicon compounds 莫门蒂夫性能材料股份有限公司 2020-09-22 CN disclosed
CN-107311873-B Method for preparing 2, 6-dichloro-4-trifluoromethylaniline with 99% content LIANYUNGANG AVILIVE CHEMICAL CO., LTD. (CN) 2019-12-10 CN disclosed
WO-2019067702-A9 SMALL MOLECULE INHIBITORS OF GALECTIN-3 BRISTOL-MYERS SQUIBB COMPANY (US) 2019-04-25 WO disclosed
WO-2019067702-A9 SMALL MOLECULE INHIBITORS OF GALECTIN-3 BRISTOL-MYERS SQUIBB COMPANY (US) 2019-04-25 WO disclosed
WO-2019067702-A1 SMALL MOLECULE INHIBITORS OF GALECTIN-3 BRISTOL-MYERS SQUIBB COMPANY (US) 2019-04-04 WO disclosed
WO-2019067702-A1 SMALL MOLECULE INHIBITORS OF GALECTIN-3 BRISTOL-MYERS SQUIBB COMPANY (US) 2019-04-04 WO disclosed
WO-2015095788-A1 2-ACYLAMIDOMETHYL AND SULFONYLAMIDOMETHYL BENZOXAZINE CARBAMATES FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE MERCK SHARP & DOHME CORP. (US) 2015-06-25 WO disclosed
EP-2595985-A1 ISOXAZOLE, ISOTHIAZOLE, FURANE AND THIOPHENE COMPOUNDS AS MICROBICIDES Syngenta Participations AG (CH) 2013-05-29 EP disclosed
WO-2012010567-A1 ISOXAZOLE, ISOTHIAZOLE, FURANE AND THIOPHENE COMPOUNDS AS MICROBICIDES SYNGENTA PARTICIPATIONS AG (CH) 2012-01-26 WO disclosed
US-6034086-A VIRICIDES; AIDS THERAPY UBE INDUSTRIES, LTD. 2000-03-07 US disclosed
EP-0206951-B1 PROCESS FOR THE PERFLUOROALKYLATION OF AROMATIC DERIVATIVES RHONE-POULENC CHIMIE (FR) 1990-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147408-A1 SMALL MOLECULE INHIBITORS OF GALECTIN-3 LGALS3, LGALS1, LGALS3BP SLC6A4 4385/4885SLC6A2 4224/4885SLC6A3 2017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.